BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 11, 2005
View Archived Issues
Clearance for phase I study of 1D09C3 in Germany
Read More
PainCeptor selects preclinical development lead candidates for key programs
Read More
Edison receives FARA grant to develop EPI-A0001 for Friedreich's ataxia
Read More
CTCE-9908 prevents human prostate cancer metastases in preclinical study
Read More
New phase I study for Heplisav HBV vaccine
Read More
Epitan reports results from European PMLE phase II study of EPT-1647
Read More
Weight loss seen in phase I study of oleoyl-estrone
Read More
Nicholas Piramal to acquire Avecia Pharmaceuticals
Read More
InterMune enrolls 600th patient in pivotal INSPIRE study
Read More
Approval for phase I study in Stem Cell Therapeutics' stroke program
Read More
European phase II trial studies Uvidem for melanoma
Read More
Aphton and sanofi pasteur to terminate Insegia agreements
Read More
European approval for Zeldox for manic or mixed episodes in bipolar disorder
Read More
Recent Ligand patent discloses novel androgen receptor modulators
Read More
Recent patents cover novel treatments for neurological disorders
Read More
Boehringer Ingelheim patents novel agents for treating inflammation
Read More
AVE-8062 reported to prevent proliferation of solid tumors in rats
Read More
KLF5 antagonists may play a role in the treatment of vascular diseases
Read More
SELENBP1 identified as candidate gene for schizophrenia using novel approach
Read More
New broad-spectrum antibiotics with a novel mechanism of action
Read More
Lentivirus-mediated gene therapy for sickle cell anemia and thalassemia to soon enter clinical trial
Read More
